11 – 20 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Risk stratification and treatment goals in pulmonary arterial hypertension
(
- Contribution to journal › Scientific review
-
Mark
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Right ventricular dyssynchrony predicts outcome in pulmonary arterial hypertension when assessed in multiple cardiac magnetic resonance views
(
- Contribution to journal › Article
-
Mark
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10–12 Years After Heart Transplantation : The Results of a Randomized Controlled Trial (SCHEDULE Trial)
(
- Contribution to journal › Article
-
Mark
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions
(
- Contribution to journal › Scientific review
- 2023
-
Mark
The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension : A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
(
- Contribution to journal › Letter
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article
-
Mark
Societal costs associated to chronic thromboembolic pulmonary hypertension : A study utilizing linked national registries
(
- Contribution to journal › Article
-
Mark
Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension : A Swedish single-center study
(
- Contribution to journal › Article